Baird Financial Group Portfolio holdings
AUM
$57B
1-Year Return
20.87%
This Quarter Return
+7.77%
1 Year Return
+20.87%
3 Year Return
+74.96%
5 Year Return
+130.49%
10 Year Return
+303.64%
AUM
$51.5B
AUM Growth
+$3.29B
(+6.8%)
Cap. Flow
+$97.5M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
24.01%
Holding
1,850
New
97
Increased
775
Reduced
779
Closed
103
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$131M |
| 2 |
Rollins
ROL
|
$58.5M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
$56.2M |
| 4 |
GE Aerospace
GE
|
$54M |
| 5 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
$52.6M |
Top Sells
| 1 |
Watsco
WSO
|
$77.1M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$55.7M |
| 3 |
Aptiv
APTV
|
$53.9M |
| 4 |
Bentley Systems
BSY
|
$49.8M |
| 5 |
Lattice Semiconductor
LSCC
|
$48.2M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Financials | 13.13% |
| 3 | Industrials | 10.63% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Healthcare | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Molina Healthcare
MOH
$9.26B
| $50.7K | ﹤0.01% |
147
-2,524
| -94% | -$870K |
|
1727
OPAL Fuels
OPAL
$64.4M
| $48.4K | ﹤0.01% |
13,249
| – | – |
|
1728
Pediatrix Medical
MD
$1.48B
| $46.4K | ﹤0.01% |
4,000
-13,677
| -77% | -$159K |
|
1729
Sana Biotechnology
SANA
$757M
| $41.6K | ﹤0.01% |
+10,000
| New | +$41.6K |
|
1730
Lantheus
LNTH
$3.66B
| $36.8K | ﹤0.01% |
335
-10,597
| -97% | -$1.16M |
|
|
NGD
1731
New Gold Inc
NGD
$4.86B
| $36.5K | ﹤0.01% |
12,675
+1,175
| +10% | +$3.38K |
|
1732
Walker & Dunlop
WD
$2.84B
| $35.9K | ﹤0.01% |
+316
| New | +$35.9K |
|
1733
B2Gold
BTG
$5.34B
| $32.3K | ﹤0.01% |
10,500
-2,000
| -16% | -$6.16K |
|
|
CLLS
1734
Cellectis
CLLS
$264M
| $32K | ﹤0.01% |
15,090
| – | – |
|
1735
Karyopharm Therapeutics
KPTI
$58.4M
| $31.4K | ﹤0.01% |
2,520
+67
| +3% | +$834 |
|
1736
Globalstar
GSAT
$3.89B
| $31K | ﹤0.01% |
1,667
| – | – |
|
1737
Enhabit
EHAB
$398M
| $30.7K | ﹤0.01% |
3,886
-7,248
| -65% | -$57.3K |
|
1738
Entegris
ENTG
$12.1B
| $27K | ﹤0.01% |
+240
| New | +$27K |
|
1739
ChargePoint
CHPT
$238M
| $23.6K | ﹤0.01% |
861
-540
| -39% | -$14.8K |
|
1740
Wallbox
WBX
$65.4M
| $23.1K | ﹤0.01% |
947
-39
| -4% | -$951 |
|
1741
Akebia Therapeutics
AKBA
$801M
| $23K | ﹤0.01% |
17,393
| – | – |
|
1742
Cerus
CERS
$255M
| $20.8K | ﹤0.01% |
11,950
| – | – |
|
1743
Encompass Health
EHC
$12.5B
| $19.3K | ﹤0.01% |
+200
| New | +$19.3K |
|
|
BLUE
1744
DELISTED
bluebird bio
BLUE
| $16.8K | ﹤0.01% |
1,613
-1,500
| -48% | -$15.6K |
|
|
NAK
1745
Northern Dynasty Minerals
NAK
$471M
| $10.1K | ﹤0.01% |
30,600
| – | – |
|
|
CMRX
1746
DELISTED
Chimerix, Inc.
CMRX
| $9.3K | ﹤0.01% |
10,000
| – | – |
|
|
AVK.RT
1747
DELISTED
Advent Convertible and Income Fund Rights (expiring October 17, 2024)
AVK.RT
| $4.09K | ﹤0.01% |
+205,705
| New | +$4.09K |
|
1748
Alcoa
AA
$8.1B
| – | – |
-90,219
| Closed | -$3.59M |
|
1749
AMN Healthcare
AMN
$775M
| – | – |
-14,173
| Closed | -$726K |
|
1750
Antero Resources
AR
$10B
| – | – |
-10,014
| Closed | -$327K |
|